Slider Versus Tensioner Neural Mobilization in Diabetic Peripheral Neuropathy

NCT05349357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2023-03-09

No results posted yet for this study

Summary

Neurodynamics, i.e., the mobilization of the peripheral nervous system, is a physical approach to the treatment of pain; the method relies on influencing pain physiology via mechanical treatment of neural tissues and the non-neural structures surrounding the nervous system. Neural mobilization (NM) is used to treat various disorders of the nervous system concerning the length and mobility of peripheral nerves, as the nerve mobilizing refers to techniques that help to reestablish motion between a nerve and its surrounding soft tissues, thus to treat the nerves that have become entangled within the soft tissue, as it leads to tension release on a nerve by stretching and pulling one end of the nerve during keeping the other end in a relaxed state.

Conditions

  • Diabetic Peripheral Neuropathic Pain

Interventions

OTHER

Sliding Neural mobilization

Sliding neural mobilization to femoral, sciatic and tibial nerve

OTHER

Tensioner Neural mobilization

Tensioner neural mobilization to femoral, sciatic and tibial nerve

OTHER

Stretching exercises

Stretching exercises

DEVICE

TENS

TENS

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Mirza Obaid Baig, MSPT(NMR) · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-25
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05349357 on ClinicalTrials.gov